Pharmacokinetic study of the oral fluorouracil antitumor agent S-1 in patients with impaired renal function

number of downloads : ?

Use this link to cite this item : https://ir.lib.shimane-u.ac.jp/52942

language	eng
Author	Goto, Keiko Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan Department of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan Fujiwara, Yutaka Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan Department of Experimental Therapeutics, National Cancer Center Hospital, Shimane, Tokyo Division of Respiratory Medicine, Mitsui Memorial Hospital, Tokyo, Japan Isobe, Takeshi Chayahara, Naoko Department of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan Kiyota, Naomi Department of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan Mukohara, Toru Department of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan Department of Breast and Medical Oncology, National Cancer Center Hospital East, Kashiwa, Japan Tsubata, Yukari HOTTA, Takamasa Tamura, Kenji Department of Breast and Medical Oncology, National Cancer Center Hospital, Tokyo, Japan Yamamoto, Noboru Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan Department of Experimental Therapeutics, National Cancer Center Hospital, Shimane, Tokyo Minami, Hironobu Department of Medical Oncology and Hematology, Kobe University Graduate School of Medicine, Kobe, Japan
Subject	5-fluorouracil; CDHP; clearance; eGFR; S-1
Journal Title	CANCER SCIENCE
Volume	110
Issue	6
Start Page	1987
End Page	1994
ISSN	1347-9032
ISSN（Online）	1349-7006
Published Date	2019-06
DOI	10.1111/cas.14025
PubMed ID	30989775
Publisher	WILEY
NII Type	Journal Article
OAI-PMH Set	Faculty of Medicine
Remark	Ministry of Health, Labour and Welfare, Grant/Award Number: 23-A-16